Medindia

X

Jubilant Gets FDA Nod for Generic Diuretic Medicine

by Kathy Jones on  April 28, 2014 at 6:15 PM Corporate News   - G J E 4
Jubilant Life Sciences announced on Friday that it has received approval from the US Food and Drugs Administration (FDA) to market a generic diuretic medicine.
 Jubilant Gets FDA Nod for Generic Diuretic Medicine
Jubilant Gets FDA Nod for Generic Diuretic Medicine
Advertisement

The company has received abbreviated new drug application approval to market Spironolactone tablets (25 mg, 50 mg and 100 mg). These tablets are the generic version of GD Searle's Aldactone. Spironolactone is used to treat fluid retention caused by conditions such as congestive heart failure and cirrhosis of the liver.

Advertisement
Jubilant said in a press release that it will launch the drug in the first quarter of the fiscal year 2015-16. The market size of this diuretic is estimated to be $87 million per year.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All